Synonym: N-[4-Methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2´-methyl-4´-(5-methyl-1,2,4-oxadiazol-3-yl)-1,1´-biphenyl-4-carboxamide hydrochloride hydrate
CAS Number: 148642-42-6 (anhydrous)
Empirical Formula (Hill Notation): C29H31N5O3 · HCl · xH2O
Molecular Weight: 534.05 (anhydrous basis)
MDL Number: MFCD11045922
Linear Formula: C29H31N5O3 · HCl · xH2O
Product Type: Chemical
| assay |
>98% (HPLC) |
| color |
white to beige |
| form |
powder |
| InChI |
1S/C29H31N5O3.ClH.H2O/c1-19-17-23(28-30-20(2)37-32-28)9-11-25(19)21-5-7-22(8-6-21)29(35)31-24-10-12-27(36-4)26(18-24)34-15-13-33(3)14-16-34;;/h5-12,17-18H,13-16H2,1-4H3,(H,31,35);1H;1H2 |
| InChI key |
KSXUSAQPMSACQS-UHFFFAOYSA-N |
| originator |
GlaxoSmithKline |
| Quality Level |
100  |
| SMILES string |
O.Cl.COc1ccc(NC(=O)c2ccc(cc2)-c3ccc(cc3C)-c4noc(C)n4)cc1N5CCN(C)CC5 |
| solubility |
DMSO: 10 mg/mL, clear |
| storage condition |
desiccated |
| storage temp. |
2-8°C |
| Biochem/physiol Actions: |
Potent, selective and orally active 5-HT1B/1D serotonin receptor antagonist. |
| Disclaimer: |
Desiccate |
| Features and Benefits: |
This compound was developed by GlaxoSmithKline . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Legal Information: |
Sold for research purposes under agreement from GlaxoSmithKline |
| Packaging: |
10, 50 mg in glass bottle |
| RIDADR |
NONH for all modes of transport |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
| Purity |
>98% (HPLC) |
| Storage Temp. |
2-8°C |
| UNSPSC |
12352200 |
